NCT04029519View on ClinicalTrials.gov

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 21, 2018

Primary Completion Date

August 27, 2019

Study Completion Date

August 27, 2019

Conditions

Lip Augmentation

Interventions

DEVICE

PN40082

PN40082 (manufactured by Prollenium Medical Technologies) is a clear, colorless gel in 1.0 mL pre-filled syringes with 25 mg/mL of stabilized hyaluronic acid and lidocaine 0.3% w/w.

Trial Locations (6)

10022

Schweiger Dermatology, PLLC, New York

33144

International Dermatology Research, Inc, Miami

37215

Tennessee Clinical Research Center, Nashville

68144

Skin Specialists, PC, Omaha

75093

Skintastic, Plano

92024

California Dermatology & Clinical Research Institute, Encinitas

All Listed Sponsors

collaborator

Symbio, LLC

INDUSTRY

lead

Prollenium Medical Technologies Inc.

INDUSTRY

NCT04029519 - A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation | Biotech Hunter | Biotech Hunter